</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#E9EBF2" bgcolor="#E9EBF2">
CB Partner Webinar {{webinarsautomatedemailsthankyou::omeda}} #EVENTTITLE# {{webinarsautomatedemailsthankyou::round_table}} Purina{reg} {{webinarsautomatedemailsthankyou::client_only_logo}} {{webinarsautomatedemailsthankyou::client_only_logo_self_hosted}} {{webinarsautomatedemailsthankyou::client_only_logo_alt}} {{webinarsautomatedemailsthankyou::client_only_logo_width}} {{webinarsautomatedemailsthankyou::client_only_logo_custom_css}} {{webinarsautomatedemailsthankyou::client_color}} {{webinarsautomatedemailsthankyou::supported_by}} We hope you found the information helpful in the treatment and management of canine epilepsy and cognitive dysfunction syndrome. Canine epilepsy can be a challenging and unpredictable condition. To diagnose and manage it most appropriately, clinicians must be able to distinguish structural from idiopathic epilepsy, rule out other causes of seizures, and differentiate epileptic seizures from other paroxysmal events. Idiopathic epilepsy can significantly impact dogs and their owners. The goals of therapeutic management should include reducing seizure frequency, minimizing adverse effects from medications, and improving overall quality of life for the patient and owner. Studies support the use of medium-chain triglycerides to reduce seizure frequency and may also help mitigate behavior-related comorbidities. Canine cognitive dysfunction syndrome (CDS) is an age-related, gradual, progressive, neurodegenerative disorder affecting memory, learning, perception, and awareness. The prevalence of CDS in dogs older than 8 years of age may range from 14% to more than 60%, but only 1.9% of dogs are currently diagnosed. To aid in the early diagnosis of CDS, dogs older than 8 years of age should have 2 exams performed annually, along with laboratory tests and a cognitive assessment questionnaire (DISHAA). Medium-chain triglycerides, along with a unique blend of antioxidants, arginine, B vitamins, and EPA + DHA, have been shown to improve signs of canine CDS. Purina® Pro Plan® Veterinary Diets NC NeuroCare™ Canine Formula is indicated for CDS and idiopathic epilepsy as an adjunct to veterinary therapy.

Download a printable PDF of these takeaways.

{{webinarsautomatedemailsthankyou::printable_pdf_url}}

Please note that a minimum of 50 minutes worth of attendance during the live event was required to receive your certificate. If you did not download your CE certificate during the event, click here to download your certificate.

If you did not meet the 50-minute minimum, please view the on-demand version here and complete a 5-question quiz to receive your certificate.

{{webinarsautomatedemailsthankyou::ce_certificate_url}} #AUDIENCEURL# true
Dear #FIRSTNAME#,
Thank you for attending our webinar, "#EVENTTITLE#," sponsored by Purina{reg}. We hope you found the information helpful in the treatment and management of canine epilepsy and cognitive dysfunction syndrome. Thank you for attending our webinar, "#EVENTTITLE#." We hope you found the information helpful in the treatment and management of canine epilepsy and cognitive dysfunction syndrome.
Below you will find the Top 5 Takeaways from the webinar.
Top 5 Takeaways
  1. Canine epilepsy can be a challenging and unpredictable condition. To diagnose and manage it most appropriately, clinicians must be able to distinguish structural from idiopathic epilepsy, rule out other causes of seizures, and differentiate epileptic seizures from other paroxysmal events.
  2. Idiopathic epilepsy can significantly impact dogs and their owners. The goals of therapeutic management should include reducing seizure frequency, minimizing adverse effects from medications, and improving overall quality of life for the patient and owner. Studies support the use of medium-chain triglycerides to reduce seizure frequency and may also help mitigate behavior-related comorbidities.
  3. Canine cognitive dysfunction syndrome (CDS) is an age-related, gradual, progressive, neurodegenerative disorder affecting memory, learning, perception, and awareness. The prevalence of CDS in dogs older than 8 years of age may range from 14% to more than 60%, but only 1.9% of dogs are currently diagnosed.
  4. To aid in the early diagnosis of CDS, dogs older than 8 years of age should have 2 exams performed annually, along with laboratory tests and a cognitive assessment questionnaire (DISHAA).
  5. Medium-chain triglycerides, along with a unique blend of antioxidants, arginine, B vitamins, and EPA + DHA, have been shown to improve signs of canine CDS. Purina® Pro Plan® Veterinary Diets NC NeuroCare™ Canine Formula is indicated for CDS and idiopathic epilepsy as an adjunct to veterinary therapy.

Download a printable PDF of these takeaways.

Your CE Certificate

Please note that a minimum of 50 minutes worth of attendance during the live event was required to receive your certificate. If you did not download your CE certificate during the event, click here to download your certificate.

If you did not meet the 50-minute minimum, please view the on-demand version here and complete a 5-question quiz to receive your certificate.

Feel free to pass this along to colleagues who may be interested.
If you would like to reference the on‑demand version of the event, click here.
Thanks again for attending,
The Clinician's Brief Team
The Purina{reg} Team
</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#E9EBF2" bgcolor="#E9EBF2">
Dear #FIRSTNAME#,
Thank you for attending our webinar, "#EVENTTITLE#," sponsored by Purina{reg}. We hope you found the information helpful in the treatment and management of canine epilepsy and cognitive dysfunction syndrome. Thank you for attending our webinar, "#EVENTTITLE#." We hope you found the information helpful in the treatment and management of canine epilepsy and cognitive dysfunction syndrome.
Below you will find the Top 5 Takeaways from the webinar.
Top 5 Takeaways
  1. Canine epilepsy can be a challenging and unpredictable condition. To diagnose and manage it most appropriately, clinicians must be able to distinguish structural from idiopathic epilepsy, rule out other causes of seizures, and differentiate epileptic seizures from other paroxysmal events.
  2. Idiopathic epilepsy can significantly impact dogs and their owners. The goals of therapeutic management should include reducing seizure frequency, minimizing adverse effects from medications, and improving overall quality of life for the patient and owner. Studies support the use of medium-chain triglycerides to reduce seizure frequency and may also help mitigate behavior-related comorbidities.
  3. Canine cognitive dysfunction syndrome (CDS) is an age-related, gradual, progressive, neurodegenerative disorder affecting memory, learning, perception, and awareness. The prevalence of CDS in dogs older than 8 years of age may range from 14% to more than 60%, but only 1.9% of dogs are currently diagnosed.
  4. To aid in the early diagnosis of CDS, dogs older than 8 years of age should have 2 exams performed annually, along with laboratory tests and a cognitive assessment questionnaire (DISHAA).
  5. Medium-chain triglycerides, along with a unique blend of antioxidants, arginine, B vitamins, and EPA + DHA, have been shown to improve signs of canine CDS. Purina® Pro Plan® Veterinary Diets NC NeuroCare™ Canine Formula is indicated for CDS and idiopathic epilepsy as an adjunct to veterinary therapy.

Download a printable PDF of these takeaways.

Your CE Certificate

Please note that a minimum of 50 minutes worth of attendance during the live event was required to receive your certificate. If you did not download your CE certificate during the event, click here to download your certificate.

If you did not meet the 50-minute minimum, please view the on-demand version here and complete a 5-question quiz to receive your certificate.

Feel free to pass this along to colleagues who may be interested.
If you would like to reference the on‑demand version of the event, click here.
Thanks again for attending,
The Clinician's Brief Team
The Purina{reg} Team